Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-032671

Options or other derivatives

  • Director acquired 27,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bray June · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-24 Grant or award : show line 1 in the form Stock Option (right to buy) +27,000 27,000 D
Loading xslF345X04/doc4.xml…